NovaBridge Biosciences Dividends

The next dividend date for NovaBridge Biosciences has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for NovaBridge Biosciences (NBP)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About NovaBridge Biosciences

Country
USA
Full Time Employees
30

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies; Phase 1b clinical trial in combination with nivolumab and chemotherapy in first-line gastric cancer. The company also develops VIS-101, VEGF-A × ANG-2 bispecific biologics in Phase 2 clinical trial to treat wet age-related macular degeneration and other retinal diseases, including diabetic macular edema; ragistomag, which is in Phase 1clinical trial for multiple solid tumors. It has a licensing agreement with AskGene to develop and commercialize VIS-101; collaborations with Bristol Myers Squibb for the development of givastomig; and license and collaboration agreement with AbbVie Ireland Unlimited Company for the development and commercialization of lemzoparlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

Owning NovaBridge Biosciences Stock on the Dividend Date

If you own NovaBridge Biosciences stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of NovaBridge Biosciences stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of NovaBridge Biosciences stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying NovaBridge Biosciences stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the NovaBridge Biosciences dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More NovaBridge Biosciences Dividends

You can contact us any time if you would like to ask questions about NovaBridge Biosciences dividends or anything else related to the stock market.